Currently Works at the Neuromuscular Disorders Group, Biobizkaia Health Research Institute.
Research line:
Advanced therapies for neuromuscular disorders: antisense oligonucleotides, RNA therapy.Miguel Servet Fellowship I and II, Institute of Health Carlos III, Spain, 2013-2021); Outstanding Mentor Award, Society of Spanish Researchers in UK (2017); Marie-Skłodowska-Curie Career Integration Grant, European Union (2013–2017).
Previous research experience in amyotrophic lateral sclerosis (King’s College London, UK) and eteplirsen clinical trials for Duchenne muscular dystrophy (Imperial College London and University College London, UK).
PhD in Neuroloy (2005) from King’s College London, United Kingdom.
.png)
